{
  "meta": {
    "disclaimer": "Do not rely on openFDA to make decisions regarding medical care. While we make every effort to ensure that data is accurate, you should assume all results are unvalidated. We may limit or otherwise restrict your access to the API in line with our Terms of Service.",
    "terms": "https://open.fda.gov/terms/",
    "license": "https://open.fda.gov/license/",
    "last_updated": "2026-04-01",
    "results": {
      "skip": 0,
      "limit": 1,
      "total": 1
    }
  },
  "results": [
    {
      "country": "United States",
      "city": "Horsham",
      "address_1": "425 Privet Rd",
      "reason_for_recall": "CGMP Deviations",
      "address_2": "",
      "product_quantity": "14,661 vials",
      "code_info": "All Lots Within Expiry  Lot# 2710715, 2720715, 2730715, 3110715, 3120715",
      "center_classification_date": "20160907",
      "distribution_pattern": "Nationwide and Puerto Rico",
      "state": "PA",
      "product_description": "Eptifibatide Injection 75 mg/100 mL (0.75 mg/mL) single use vial, For Intravenous Use Only, Rx Only, Manufactured in Hungary for TEVA PHARMACEUTICALS USA, INC., North Wales, PA 19454, NDC# 0703-1179-01.",
      "report_date": "20160914",
      "classification": "Class II",
      "openfda": {},
      "recalling_firm": "Teva North America",
      "recall_number": "D-1496-2016",
      "initial_firm_notification": "Letter",
      "product_type": "Drugs",
      "event_id": "74497",
      "termination_date": "20170207",
      "more_code_info": "",
      "recall_initiation_date": "20160617",
      "postal_code": "19044-1220",
      "voluntary_mandated": "Voluntary: Firm initiated",
      "status": "Terminated"
    }
  ]
}